Pharmacy

Eli Lilly scoops injectable manufacturing site from Nexus

Eli Lilly will acquire a Wisconsin-based injectable manufacturing facility from Nexus Pharmaceuticals, a drugmaker in Illinois.

By: Paige Twenter

Tuesday, April 23rd, 2024

The site in Pleasant Prairie, Wis., will expand Eli Lilly’s global injectable portfolio, the company said April 22. The facility is expected to begin production in late 2025.

AI in healthcare finance — Why automating the routine is the small prize

Tuesday, September 29

1:00 PM - 2:00 PM CDT

Presenters: Frank Stevens, StrataJosh Wiggins, Strata

Beyond Navigation: How Evry Health and Color Are Transforming Cancer Care for a Fully-Insured Population

Wednesday, September 30

1:00 PM - 2:00 PM CDT

Presenters: Dany Matar, ColorDr. Rebecca Miksad, ColorDr. Glenn Hamilton, Evry HealthChristina Rassi, Evry Health

Next Up in Pharmacy

Millions of Americans could lose access to cheap Canadian prescriptions next month: 3 notes

New customs requirements taking effect Oct. 22 could disrupt access for millions of Americans who buy prescription drugs from Canadian…

By: Ella Jeffries
7 hours ago
AHA seeks permanent 340B rebate ban: 6 things to know

The American Hospital Association is urging Congress to permanently bar rebate models in the 340B program. AHA issued the request…

By: Mackenzie Bean
8 hours ago
FDA approves Eli Lilly's weekly insulin injection

Eli Lilly received FDA approval Sept. 24 for Onswik, a once-weekly basal insulin injection for adults with Type 2 diabetes.…

By: Mackenzie Bean
10 hours ago

Comments are closed.

Next Up in Pharmacy

Join the 500,000+ healthcare executives who start their day with Becker's